Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Research analysts at Roth Capital raised their Q3 2025 earnings per share estimates for Aurora Cannabis in a research report issued on Wednesday, August 7th. Roth Capital analyst W. Kirk now anticipates that the company will post earnings of $0.00 per share for the quarter, up from their previous estimate of ($0.09). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.50) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q4 2025 earnings at $0.04 EPS.
Aurora Cannabis Stock Performance
Shares of ACB stock opened at $6.69 on Monday. The business’s 50 day simple moving average is $5.69 and its 200 day simple moving average is $5.37. Aurora Cannabis has a one year low of $2.84 and a one year high of $11.50. The stock has a market capitalization of $364.91 million, a PE ratio of -4.78 and a beta of 1.86. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.42 and a quick ratio of 1.93.
Institutional Trading of Aurora Cannabis
Institutional investors have recently added to or reduced their stakes in the stock. Mackenzie Financial Corp bought a new position in shares of Aurora Cannabis during the 4th quarter worth approximately $98,000. Virtu Financial LLC bought a new position in shares of Aurora Cannabis during the 1st quarter worth approximately $727,000. Vanguard Personalized Indexing Management LLC bought a new position in Aurora Cannabis during the fourth quarter worth $42,000. Headlands Technologies LLC grew its holdings in Aurora Cannabis by 98.8% in the second quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock worth $346,000 after purchasing an additional 37,269 shares during the period. Finally, TD Asset Management Inc bought a new stake in Aurora Cannabis in the second quarter valued at $255,000. 47.63% of the stock is currently owned by institutional investors.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
- Five stocks we like better than Aurora Cannabis
- What is the NASDAQ Stock Exchange?
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- How to buy stock: A step-by-step guide for beginners
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.